Skip to main content Skip to main navigation Skip to search Skip to footer

HCL's R&D Transformation

HCL's R&D Transformation

Life Sciences industry is undergoing a transformational change - blockbuster patent expirations, global interconnected world, and increased regulatory scrutiny. We are at the verge of transitioning to personalized medicine, enabled by translational research and technological innovation. The traditional models through which the Pharma companies operated are becoming obsolete with the emergence of a new ecosystem of partnership driven by externalization & enhanced collaborations with IT providers and functional service providers alike. Pharma companies adopt one or more of the models below for their clinical needs, based on their outsourcing maturity.

Kontaktieren Sie uns
MAX CHARACTERS: 10,000

We will treat any information you submit with us as confidential. Please read our privacy statement for additional information.

We will treat any information you submit with us as confidential. Please read our privacy statement for additional information.